Coronavirus Now: COVID-19 Updates for July 30

As of July 30, confirmed cases of COVID-19 now number at more than 17 million around the world, including more than 4.5 million cases in the United States and more than 153,000 U.S. deaths. You can see a breakdown of coronavirus cases throughout the world and within the U.S. on the map and chart above.

Below you’ll find updates on the latest news about the coronavirus.


July 30 News Updates

Coronavirus Cases Worldwide Now Exceed 17 Million

For the first time, coronavirus cases worldwide now exceed 17 million. This includes more than 4.5 million cases from the United States alone, more than 2.5 million from Brazil, and more than 1.5 million from India. No other countries currently have more than a million cases.

Fauci Said ‘Valid’ Scientific Data Doesn’t Support Hydroxychloroquine for COVID-19 Treatment

Dr. Anthony Fauci has said that current “valid” scientific data doesn’t support hydroxychloroquine as an effective coronavirus treatment, CNBC reported. He said that randomized and controlled trials aren’t showing that it’s effective.

He added: “If a study that’s good comes out and shows efficacy and safety for hydroxychloroquine or any other drug that we do … you accept the scientific data. Right now, today, the cumulative scientific data that has been put together and done over a number of different studies have shown no efficacy.”

Ohio Is Banning Hydroxychloroquine as Treatment for COVID-19 Outside of Clinical Trials

The State of Ohio Board of Pharmacy has issued new regulations for hydroxychloroquine that are effective on July 30, The Columbus Dispatch reported. The drug can be used in clinical trials, but pharmacies, medical institutions, and clinics will no longer be able to dispense or sell the drug for COVID-19 use. Pharmacists who dispense the drug may face anywhere from a warning to a temporary suspension of their license. Read more in Heavy’s story here.

Vaccine Updates

GettyA woman leaves Life Care Center of Kirkland on February 29, 2020, in Kirkland, Washington.

Moderna’s new vaccine has shown promise in early trials of eight volunteers who received two doses, The New York Times reported. The vaccine showed a safe immune response. The trial will now be repeated with hundreds and later thousands of people in a July trial. The vaccine uses mRNA from the virus, which is a new process. The earliest a Moderna vaccine might be available would be the end of this year or early 2021.

Oxford University researchers have tested a vaccine that successfully works in monkeys and is being tested in Britain volunteers, WUSA9 reported in late April. If all goes well, the first few million doses could be ready as soon as September. The vaccine uses genes from a spikey protein to help the immune system make antibodies.

Bill Gates is funding factories that will test seven vaccine candidates to help mobilize vaccines faster, Business Insider reported in early April. He said: “Even though we’ll end up picking at most two of them, we’re going to fund factories for all seven, just so that we don’t waste time.”

A second potential COVID-19 vaccine is from Inovio, called the INO-4800 DNA vaccine. Inovio completed Phase 1 trial for a similar DNA vaccine for MERS. The Bill and Melinda Gates Foundation is backing this trial. Inovio announced positive results from two Phase I clinical trials in early July. The Phase 1 trial has now been expanded to include older participants, and Phase 2/3 may begin this summer. The Phase 1 trial had 40 healthy volunteers ages 18 to 50 who had 1 mg and 2 mg cohorts, with two doses taken four weeks apart. All were safe through week 8 and only 10 had minor adverse events, mostly just redness at the injection site. Analyses showed 94% had immunological response rates. The vaccine has also been shown to protect mice, preventing viral replication in their lungs.

On March 30, Johnson & Johnson announced that it will start human clinical trials for a vaccine in September, with the first round not being available until early 2021.

A clinical vaccine trial funded by NIH at Kaiser Permanente in Washington began on Monday, March 16. Forty-five people participated in the first round. The vaccine candidate code is mRNA-1273. As of May 1, about 2/3 of the participants had gotten their first of two doses, NBC News reported.

Israeli scientists have said they may be close to a vaccine, The Jerusalem Post reported. Scientists have been working on a vaccine against a bronchial disease that affected poultry. Dr. Chen Katz told The Jerusalem Post that out of luck, they had chosen a coronavirus as the proof of concept for their technology, and the DNA of COVID-19 is very similar.

Greffex in Houston has a potential vaccine ready for animal testing, Yahoo! reported. And Walter Reed and the U.S. Army have been conducting animal studies since January.


Coronavirus Trends in the United States

An interactive map from MappingSupport.com shows recent trends in deaths per state over the last 14 and 7 days. You can view the full map here. Green means the trend is decreasing, red means the deaths are increasing. Circles show the prior 14 days and triangles show the prior seven days.


Open this map full screen.

Another map sourcing the most recent news about the virus can be found here.

If you are concerned about your symptoms, talk with your doctor right away.

READ NEXT: Best N95 Masks & Respirators to Keep You Safe